Interestingly, another two studies demonstrated that USP13 could promote tumor progression by deubiquitinating Myc, ACLY and OGDH31, 32, indicating the opposite role of USP13 in tumor progression or inhibition. The gene discussed is MYC; the disease is neoplasm.